Medications That Cause Hyperuricemia
The most clinically important medications that cause hyperuricemia are thiazide and loop diuretics, niacin, and calcineurin inhibitors (cyclosporin, tacrolimus), which should be eliminated when non-essential for optimal management of comorbidities. 1
Primary Offending Medications
Diuretics (Most Common)
- Thiazide diuretics are the most prevalent cause of drug-induced hyperuricemia in clinical practice 1, 2
- Loop diuretics similarly elevate serum urate levels 1
- Mechanism: Decrease renal uric acid excretion by interfering with tubular secretion 3, 2
- Clinical significance: In thiazide users, 24.5% develop hyperuricemia versus 15.3% in non-users, with risk increasing significantly after 3-4 years of use 4
- Management approach: These should be discontinued or switched to alternative antihypertensives when possible, unless absolutely essential for conditions like heart failure 1
Calcineurin Inhibitors
- Cyclosporine and tacrolimus cause hyperuricemia through decreased renal urate clearance 1, 5
- Clinical impact: 84% of cyclosporine-treated renal transplant recipients develop hyperuricemia versus 30% on azathioprine 5
- Gout develops in 7% of cyclosporine users, representing considerable morbidity 5
- Critical caveat: These medications are typically essential for transplant patients, so discontinuation is rarely feasible
Niacin
- Explicitly identified as a medication that elevates serum urate and should be eliminated when non-essential 1
- Mechanism: Interferes with renal tubular excretion of urate 3
Additional Medications to Consider
Antitubercular Agents
- Pyrazinamide: Causes significant hyperuricemia during intensive TB treatment phase 3, 6
- 60% of patients develop uric acid levels ≥7 mg/dL after 2 months of treatment 6
- Hyperuricemia strongly associated with arthralgia (OR 14.00) 6
Other Agents
- Ethambutol: Interferes with renal uric acid excretion 3
- Salicylates: Can cause hyperuricemia depending on dose 3
- Cytotoxic agents: Increase uric acid production through cell lysis 3
- Fructose: Increases uric acid formation 3
- 2-ethylamino-1,3,4-thiadiazole: Causes uric acid underexcretion 3
Important Exception: Low-Dose Aspirin
Low-dose aspirin (≤325 mg daily) modestly elevates serum urate but should NOT be discontinued when used for cardiovascular prophylaxis in gout patients 1. The cardiovascular benefits far outweigh the negligible effects on uric acid levels in gout management.
Clinical Action Algorithm
- Review all medications in patients with hyperuricemia or gout 1
- Prioritize discontinuation of thiazide/loop diuretics, niacin, and calcineurin inhibitors when they are non-essential for comorbidity management 1
- Consider alternative agents: For hypertension, use losartan (the only angiotensin receptor blocker that increases urinary urate excretion and lowers serum urate) 7
- Do not stop low-dose aspirin for cardiovascular prophylaxis 1
- Monitor closely when medications cannot be discontinued (e.g., transplant patients on calcineurin inhibitors) 5
Key Pitfall to Avoid
Do not assume that simply having hyperuricemia from medications requires treatment. Pharmacologic treatment of asymptomatic hyperuricemia is not recommended to prevent gouty arthritis, renal disease, or cardiovascular events 8, 9. Focus on eliminating causative medications first, then treat only if symptomatic gout develops or specific high-risk features are present (tophi, frequent flares >2/year, radiographic damage) 9.